Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Roivant Sciences (ROIV) Return on Equity (2021 - 2025)

Roivant Sciences (ROIV) has disclosed Return on Equity for 5 consecutive years, with 0.07% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Return on Equity rose 12.0% year-over-year to 0.07%, compared with a TTM value of 0.07% through Sep 2025, up 12.0%, and an annual FY2025 reading of 0.07%, changed N/A over the prior year.
  • Return on Equity was 0.07% for Q3 2025 at Roivant Sciences, up from 0.02% in the prior quarter.
  • Across five years, Return on Equity topped out at 0.07% in Q3 2025 and bottomed at 0.72% in Q4 2022.
  • Average Return on Equity over 5 years is 0.3%, with a median of 0.12% recorded in 2023.
  • The sharpest move saw Return on Equity plummeted -63bps in 2022, then soared 67bps in 2024.
  • Year by year, Return on Equity stood at 0.47% in 2021, then crashed by -54bps to 0.72% in 2022, then soared by 83bps to 0.12% in 2023, then soared by 109bps to 0.01% in 2024, then surged by 545bps to 0.07% in 2025.
  • Business Quant data shows Return on Equity for ROIV at 0.07% in Q3 2025, 0.02% in Q2 2025, and 0.01% in Q1 2025.